UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial

Journal of clinical oncology, 1995-10, Vol.13 (10), p.2483-2489

1995

Volltextzugriff (PDF)

Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate

Journal of clinical oncology, 1998-02, Vol.16 (2), p.453-461

1998

Volltextzugriff (PDF)

Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer

Journal of clinical oncology, 1997-02, Vol.15 (2), p.744-749

1997

Volltextzugriff (PDF)

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

Journal of clinical oncology, 1999-05, Vol.17 (5), p.1413-1424

1999

Volltextzugriff (PDF)

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study

Journal of clinical oncology, 1994-08, Vol.12 (8), p.1535-1540

1994

Volltextzugriff (PDF)

Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer

Journal of clinical oncology, 1995-10, Vol.13 (10), p.2556-2566

1995

Volltextzugriff (PDF)

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

Radiotherapy and oncology, 2009-07, Vol.92 (1), p.4-14

2009

Volltextzugriff (PDF)

Tissue platelet derived-growth factor (PDGF) predicts for shortened survival and treatment failure in advanced breast cancer

Breast cancer research and treatment, 1993, Vol.26 (3), p.247-252

1993

Volltextzugriff (PDF)

Soluble c-erbB-2 fragment in serum correlates with disease stage and predicts for shortened survival in patients with early-stage and advanced breast cancer

British journal of cancer, 1994-10, Vol.70 (4), p.739-742

1994

Volltextzugriff (PDF)

Association between human immunodeficiency virus type 1 infection and cancer in the black population of Johannesburg and Soweto, South Africa

British journal of cancer, 1997, Vol.75 (11), p.1704-1707

1997

Volltextzugriff (PDF)

A Randomized, Double-Blind Trial of Famciclovir Versus Acyclovir for the Treatment of Localized Dermatomal Herpes Zoster in Immunocompromised Patients

Cancer investigation, 2001, Vol.19 (1), p.13-22

2001

Volltextzugriff (PDF)

Positive immunostaining for platelet derived growth factor (PDGF) is an adverse prognostic factor in patients with advanced breast cancer

Breast cancer research and treatment, 1994, Vol.32 (2), p.229-233

1994

Volltextzugriff (PDF)

c-erb-B2 expression and response to treatment in metastatic breast cancer

Medical oncology (Northwood, London, England), 2000-02, Vol.17 (1), p.22-28

BEZWODA, W. R

2000

Volltextzugriff (PDF)

Induction of Alkylator (Melphalan) Resistance in HL60 Cells Is Accompanied by Increased Levels of Topoisomerase II Expression and Function

Molecular pharmacology, 1999-07, Vol.56 (1), p.147-153

1999

Volltextzugriff (PDF)

Platelet-derived growth factor (PDGF) in plasma of breast cancer patients : correlation with stage and rate of progression

Breast cancer research and treatment, 1991-12, Vol.20 (1), p.11-17

1991

Volltextzugriff (PDF)

Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma

Journal of clinical oncology, 1997-02, Vol.15 (2), p.660-666

1997

Volltextzugriff (PDF)

Interferon plus tamoxifen treatment for advanced breast cancer: in vivo biologic effects of two growth modulators

British journal of cancer, 1993-08, Vol.68 (2), p.352-356

1993

Volltextzugriff (PDF)

Interleukin‐4 prevents spontaneous in‐vitro apoptosis in chronic lymphatic leukaemia but sensitizes B‐CLL cells to melphalan cytotoxicity

British journal of haematology, 1997-08, Vol.98 (2), p.413-417

1997

Volltextzugriff (PDF)

The treatment of disseminated malignant melanoma with special reference to the role of interferons, vinca alkaloids and tamoxifen

Cancer Treatment Reviews, 1997, Vol.23 (1), p.17-34

Bezwoda, W.R.

1997

Volltextzugriff (PDF)

Alkylator resistance in human B lymphoid cell lines: (2). Increased levels of topoisomerase II expression and function in a melphalan-resistant B-CLL cell line

Anticancer research, 2000-07, Vol.20 (4), p.2569

2000

Volltextzugriff (PDF)

Lactoferrin and the inflammatory response

Advances in experimental medicine and biology, 1994, Vol.357, p.133

1994

Volltextzugriff (PDF)

High-dose chemotherapy with hematopoietic rescue in breast cancer : from theory to practice

Cancer chemotherapy and pharmacology, 1997, Vol.40, p.S79-S87

BEZWODA, W. R

1997

Volltextzugriff (PDF)

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data

The Lancet (British edition), 2000-03, Vol.355 (9208), p.949-955

2000

Volltextzugriff (PDF)

Kaposi's sarcoma in renal transplant recipients : experience at Johannesburg hospital, 1966-1989

South African medical journal, 1994, Vol.84 (1), p.16-17

1994

Volltextzugriff (PDF)

Fadrozole versus Megestrol Acetate: A Double-Blind Randomised Trial in Advanced Breast Cancer

Oncology, 1998-09, Vol.55 (5), p.416-420

1998

Volltextzugriff (PDF)

1 – 25 von 272

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(244)
Mit Volltextzugriff
(188)

Publikationsform

Artikel
(271)
Tagungsberichte
(1)

Sprache

Englisch
(272)

Erscheinungsjahr

n.n

Thema

Humans
(218)
Life Sciences & Biomedicine
(184)
Science & Technology
(184)
Female
(153)
Biological And Medical Sciences
(127)
Medical Sciences
(115)
Middle Aged
(104)
Adult
(103)
Oncology
(98)
Male
(91)
Aged
(68)
Pharmacology. Drug Treatments
(47)
Chemotherapy
(41)
General & Internal Medicine
(40)
Medicine, General & Internal
(40)
Antineoplastic Agents
(36)
Breast Neoplasms - Drug Therapy
(31)
Hematology
(31)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(29)
Prognosis
(23)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial

Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate

Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study

Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

Tissue platelet derived-growth factor (PDGF) predicts for shortened survival and treatment failure in advanced breast cancer

Soluble c-erbB-2 fragment in serum correlates with disease stage and predicts for shortened survival in patients with early-stage and advanced breast cancer

Association between human immunodeficiency virus type 1 infection and cancer in the black population of Johannesburg and Soweto, South Africa

A Randomized, Double-Blind Trial of Famciclovir Versus Acyclovir for the Treatment of Localized Dermatomal Herpes Zoster in Immunocompromised Patients

Positive immunostaining for platelet derived growth factor (PDGF) is an adverse prognostic factor in patients with advanced breast cancer

c-erb-B2 expression and response to treatment in metastatic breast cancer

Induction of Alkylator (Melphalan) Resistance in HL60 Cells Is Accompanied by Increased Levels of Topoisomerase II Expression and Function

Platelet-derived growth factor (PDGF) in plasma of breast cancer patients : correlation with stage and rate of progression

Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma

Interferon plus tamoxifen treatment for advanced breast cancer: in vivo biologic effects of two growth modulators

Interleukin‐4 prevents spontaneous in‐vitro apoptosis in chronic lymphatic leukaemia but sensitizes B‐CLL cells to melphalan cytotoxicity

The treatment of disseminated malignant melanoma with special reference to the role of interferons, vinca alkaloids and tamoxifen

Alkylator resistance in human B lymphoid cell lines: (2). Increased levels of topoisomerase II expression and function in a melphalan-resistant B-CLL cell line

Lactoferrin and the inflammatory response

High-dose chemotherapy with hematopoietic rescue in breast cancer : from theory to practice

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data

Kaposi's sarcoma in renal transplant recipients : experience at Johannesburg hospital, 1966-1989

Fadrozole versus Megestrol Acetate: A Double-Blind Randomised Trial in Advanced Breast Cancer

Suchergebnisse filtern